About Oncovision
Oncovision is a Healthcare company based in Boston (United States) founded in 2003 by Noriel Pavon, and was acquired by Bruker in September 2016. Diagnostic imaging devices for oncology are manufactured and provided. Oncovision has raised $3.84 million across 9 funding rounds from investors including Bruker, European Union and EIC Fund. Oncovision offers products and services including Mammi, Sentinella, Wprobe, and Caremibrain. Its focus areas include Life Sciences, Oncology, Medical Devices and Imaging. Its legal entity is Oncovision, Inc. Its competitors include Lantheus, Carestream and Varex.
Company details
Oncovision was founded in 2003 and is headquartered in Boston, United States. Medical and diagnostic devices focused on oncology imaging are produced by the company. Key product lines include the Sentinella intra-operative Gamma Camera and the MAMMI PET system, which enables visualization of small lesions and quantification of tumor activity in breast cancer diagnostics. Operations center on advancing oncology detection technologies.
- Headquarters Boston, United States
- Founders Noriel Pavon
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website oncovision.com
- Social LinkedIn X Facebook
- Acquired by Bruker (Sep 2016)
- Legal Name Oncovision, Inc.
Products & Services of Oncovision
Oncovision offers a comprehensive portfolio of products and services, including Mammi, Sentinella, Wprobe, and Caremibrain.
Provides precise imaging for breast cancer detection and diagnosis.
Assists in locating sentinel lymph nodes during cancer procedures.
Enables accurate detection for practical medical imaging applications.
Supports diagnosis and monitoring of Alzheimer's disease effectively.
Funding Insights of Oncovision
Oncovision has successfully raised a total of $3.84M across 9 strategic funding rounds. The most recent funding activity was a Grant round of $337.8 thousand completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.84M
- Total Rounds 9
- Last Round Grant — $337,799
- Investors Count 5
All 9 funding rounds of Oncovision with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2023 | $337,799 | Grant | – | – | |
| May 2019 | $4.89M | Grant | – | – | |
| Jun 2016 | $4.92M | Grant | – | – | |
| Mar 2016 | Grant | – | – | – | |
| Jul 2015 | Grant | – | – | – | |
| Mar 2015 | $54,250 | Grant | – | – | |
| Oct 2014 | $63,090 | Grant | – | – | |
| Sep 2012 | $3.84M | Series A | – | CRB Inverbio | |
| Jun 2006 | Seed | – | Bullnet Capital | – |
6 investors in total: 6 institutional.
Investors in Oncovision
Oncovision has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Bruker, European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
A private venture capital firm focused on life sciences investments. | crbinverbio.com | Madrid, Spain | ||
ICO Axispart is engaged in providing financial solutions for businesses. | 1971 | axispart.com | Madrid, Spain | |
High-tech Spanish startups are funded by Bullnet Capital. | bullnetcapital.com | Pozuelo de Alarcón, Spain | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Diversified research instrument systems are manufactured and supplied. | 1960 | bruker.com | United States |
Investor details for Oncovision
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Oncovision
1 people are tracked at Oncovision (1 in leadership).
| Name | Role | Group |
|---|---|---|
Noriel Pavon | Founder | Leadership |
Complete people profiles for Oncovision
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Oncovision
4 dated milestones of Oncovision across 20 years, from founding to its latest funding, stage changes and deals.
- Founded Oncovision is founded.
- Funding First funding round.
- Exit Acquired by Bruker.
- Funding Latest funding round, Grant, of $338K.
Competitors of Oncovision
Oncovision has 3 listed competitors in our database. They include Lantheus, Carestream and Varex.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lantheus.com | 2008 | Billerica, United States | 834 | Developer of diagnostic imaging agents and targeted therapeutics | ||
| carestream.com | 2007 | New York, United States | Developer of diagnostic imaging and healthcare information technology systems for hospital use | |||
| vareximaging.com | 2017 | Salt Lake, United States | 2,400 | Developer of imaging equipment and accessories |
Detailed competitors of Oncovision
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Imaging Diagnostics
3 companies that operate in the same segment as Oncovision (Imaging Diagnostics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Handheld ultrasound devices are developed for whole-body medical imaging. | 2011 | Guilford, Connecticut, United States | USD 350 M | USD 97.61 M | 464 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 | ||
Ultrasound images are analyzed via AI-based software provided by Exo. | 2015 | Redwood City, California, United States | USD 463.39 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Oncovision
Complete news archive for Oncovision
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oncovision
Oncovision was founded in 2003 and raised its 1st funding round 3 years after it was founded.
Oncovision is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Oncovision is a funded company, having raised a total of $3.84M across 9 funding rounds to date.
Oncovision was founded in 2003 and is headquartered in Boston, United States. Medical and diagnostic devices focused on oncology imaging are produced by the company. Key product lines include the Sentinella intra-operative Gamma Camera and the MAMMI PET system, which enables visualization of small lesions and quantification of tumor activity in breast cancer diagnostics. Operations center on advancing oncology detection technologies.
Oncovision's top competitors include Lantheus, Carestream and Varex.
Oncovision offers Mammi, Sentinella, Wprobe, and Caremibrain.
Oncovision has 6 investors. Key investors include Bruker, European Union, EIC Fund, CRB Inverbio, and ICO Axispart.
Oncovision operates through Oncovision, Inc..
Yes. Oncovision was acquired by Bruker in September 2016.